Eli Lilly records over $24 billion in Q3 revenue driven by demand for weight loss drugs
LLY Lilly(Eli) & Co
$1411.95 +4.28%
View chart & analysis → - 1Eli Lilly achieved revenue of over $24 billion in Q3, marking a 39% increase in revenue.
- 2Eli Lilly raised its annual guidance.
- 3CEO David Ricks said only 3% to 10% of potential patients in the U.S. are receiving weight loss care.
So what's the key point?
Eli Lilly's revenue exceeded $24 billion in Q3 due to strong sales of its weight loss medication. The company raised its annual forecast because it expects to earn more money moving forward.
Source The Motley Fool +1 · View original ↗
Today's 5 AI picks, all freeNothing hidden: past picks and how they did against the S&P 500.